While much of Valneva's focus these days is centered on its landmark vaccine for chikungunya virus, the French immunization specialist's catalog of older shots continues to serve up fresh governmen | ...

The Australian pig industry hopes work to develop a vaccine to protect its animals against Japanese encephalitis virus can be ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States (U.S.) Department of Defense (DoD) for ...

Valneva’s growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term ...

As the Japanese encephalitis vaccine was constructed using the backbone of the yellow fever vaccine, inoculation with either one of the vaccines generates T cells that are effective against both ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

There's no specific treatment for either disease, though there is a vaccine for Japanese encephalitis which may be appropriate for certain people at high risk (more on that later). Murray Valley ...

Mosquito-borne virus cases almost tripled across Queensland in 2024 amid surges in cases of Ross River virus and potentially ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $18.00.Invest ...